Shares of genetic testing company Natera (NASDAQ:NTRA). jumped 4.3% in the afternoon session after Canaccord Genuity reiterated its Buy rating on the stock after the company's strong fourth-quarter 2025 results.

The firm's positive view came after Natera's reported results exceeded its own prior forecast. Test volume increased across the company's three main business areas. Looking ahead, Natera also provided a solid revenue forecast for 2026, showing expected year-over-year growth in the mid-20% range. This combination of a strong performance and an optimistic outlook from management appeared to boost investor confidence.

After the initial pop the shares cooled down to $207.53, up 3.7% from previous close.

Is now the time to buy Natera? Access our full analysis report here, it’s free.

Natera’s shares are somewhat volatile and have had 12 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business.

The previous big move we wrote about was 4 days ago when the stock dropped 8.3% on the news that the release of a key inflation report revealed prices paid to U.S. producers rose more than anticipated in January. The Producer Price Index (PPI), which measures inflation before it reaches consumers, increased by 0.5% last month, surpassing economists' forecasts of a 0.3% rise. This report, indicating persistent inflationary pressures within the economy, sparked concerns among investors. The data suggests that the Federal Reserve might delay potential interest rate cuts that the market had been anticipating. The prospect of higher interest rates for a longer period can negatively affect corporate valuations and borrowing costs, leading to a broad market downturn that is impacting various sectors, including healthcare and medical devices.

Natera is down 9.3% since the beginning of the year, and at $207.53 per share, it is trading 18.4% below its 52-week high of $254.40 from January 2026. Investors who bought $1,000 worth of Natera’s shares 5 years ago would now be looking at an investment worth $1,909.

ONE MORE THING: The $21 AI Application Stock Wall Street Forgot. While Wall Street obsesses over who’s building AI, one company is already using it to print money. And nobody’s paying attention.

AI chip stocks trade at ridiculous valuations. This company processes a trillion consumer signals monthly using AI and trades at a third of the price. The gap won’t last. The institutions will figure it out. You need to see this first. Read the FREE Report Before They Notice.